MRP on Five Medical Devices Revised Downwards
On capping of Trade Margin by the Union Government,
91% of brands of 5 Medical Devices report downward revision
of prices up to 88%
Highest reduction in prices for Pulse Oximeters,
Blood Pressure Monitoring Machine and Nebulizer has been reported by importers
The revised MRP is effective from 20th July
2021
In a significant decision by the Union Government, National Pharmaceutical
Pricing Authority (NPPA) exercising extraordinary powers in public interest, has
capped the Trade Margin vide notification dated 13th July 2021 for five Medical
Devices.
These are:
i. Pulse Oximeter,
ii. Blood Pressure Monitoring
Machine,
iii. Nebulizer,
iv. Digital Thermometer, and
v. Glucometer.
The margin was capped up to 70% on Price to Distributor (PTD)
level. Pursuant there to, a total of 684 products/brands of these medical devices
have been reported as on 23rd July 2021 and 620 products/brands (91%) have reported
downward revision of MRP.
The maximum downward revision has been reported by imported brand
of Pulse Oximeter, showing reduction of Rs. 2,95,375 per unit. The details of price reduction are given in
the table below:
|
Sl. No |
Medical Devices |
No of Brands Reported after the Notification |
No of Brands reported Downward revision of MRP |
Maximum Reduction Reported in MRP |
|
|
|
|
|
|
Rs |
Percentage |
|
1A |
Pulse Oximeter - Finger tip |
136 |
127 (93%) |
5,150 |
88% |
|
1B |
Pulse Oximeter - Others |
73 |
62 (85%) |
2,95,375 |
47% |
|
2 |
Blood Pressure Monitoring Machine |
216 |
195 (90%) |
6,495 |
83% |
|
3 |
Nebulizer |
137 |
124 (91%) |
15,175 |
77% |
|
4 |
Digital Thermometer |
88 |
80 (91%) |
5,360 |
77% |
|
5 |
Glucometer |
34 |
32 (94%) |
1,500 |
80% |
|
|
Total |
684 |
620 (91%) |
|
|
The downward revision of MRP has been reported by imported and
domestic brands across all the categories. The highest reduction in prices for Pulse
Oximeters, Blood Pressure Monitoring Machine and Nebulizer has been reported by
importers.
The revised MRP effective from 20th July 2021 on all the brands
and specifications has been shared with the State Drug Controllers for strict monitoring
and enforcement. The relevant instructions are available on NPPA’s website (www.nppa.gov.in).
In order to monitor availability, the manufacturers / importers of these medical
devices have been directed to submit quarterly stock details.
This significant move has received support from Industry Associations
like FICCI, AdvaMed, and AMCHAM.